A. Gentry-Maharaj

857 total citations
15 papers, 316 citations indexed

About

A. Gentry-Maharaj is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Genetics. According to data from OpenAlex, A. Gentry-Maharaj has authored 15 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 4 papers in Genetics. Recurrent topics in A. Gentry-Maharaj's work include Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cervical Cancer and HPV Research (2 papers). A. Gentry-Maharaj is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cervical Cancer and HPV Research (2 papers). A. Gentry-Maharaj collaborates with scholars based in United Kingdom, United States and Belgium. A. Gentry-Maharaj's co-authors include Chloe Karpinskyj, Usha Menon, Ian Jacobs, Andy Ryan, Matthew Burnell, M. S. Hunter, Lindsay Fraser, Anne Lanceley, John F. Timms and Stuart Campbell and has published in prestigious journals such as Cancer Research, Journal of Hepatology and British Journal of Cancer.

In The Last Decade

A. Gentry-Maharaj

14 papers receiving 308 citations

Peers

Countries citing papers authored by A. Gentry-Maharaj

Since Specialization

Citations

This map shows the geographic impact of A. Gentry-Maharaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gentry-Maharaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gentry-Maharaj more than expected).

Fields of papers citing papers by A. Gentry-Maharaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gentry-Maharaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gentry-Maharaj. The network helps show where A. Gentry-Maharaj may publish in the future.

Co-authorship network of co-authors of A. Gentry-Maharaj

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gentry-Maharaj. A scholar is included among the top collaborators of A. Gentry-Maharaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gentry-Maharaj. A. Gentry-Maharaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	1064O ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer (EOC): Final overall survival (OS) analysis 2025 ·Annals of Oncology ·(unknown), Iain A. McNeish, Davide Radice, Rosemary Lord, Agnieszka Michael, Alistair Cook, (unknown), Axel Walther, Sarah P. Blagden, Dearbhaile M. O’Donnell, (unknown), (unknown), C. Sessa, (unknown), Francesco Schiavone, A. Gentry-Maharaj, (unknown), (unknown), JA Ledermann	0
2	PO008/#619 A multicentre, prospective cohort study investigating diagnostic accuracy in women with symptoms of suspected ovarian cancer (The Rockets Study): results for pre-menopausal women 2024 ·Lirias (KU Leuven) ·Sudha Sundar, Ridhi Agarwal, (unknown), Clare Davenport, Susan Mallett, Partha Pratim Sengupta, S. Johnson, (unknown), Caroline Rick, Sean Kehoe, D. Timmerman, T. Bourne, Ben Van Calster, Hilary Stobart, Richard D Neal, Usha Menon, A. Gentry-Maharaj, (unknown), Ryan Ottridge, Jonathan J Deeks	1
3	Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer 2024 ·International Journal of Gynecological Cancer ·(unknown), Caroline Kristunas, Clare Davenport, Jonathan J Deeks, Susan Mallett, Ridhi Agarwal, Sean Kehoe, D. Timmerman, T. Bourne, Hilary Stobart, Richard D Neal, Usha Menon, A. Gentry-Maharaj, J. Nicholas Brenton, Nitzan Rosenfeld, (unknown), Ryan Ottridge, Sudha Sundar, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
4	Investigating harms of testing for ovarian cancer – psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study 2024 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), Caroline Kristunas, Clare Davenport, (unknown), Jonathan J Deeks, Susan Mallett, Sean Kehoe, D. Timmerman, T. Bourne, Hilary Stobart, Richard D Neal, Usha Menon, A. Gentry-Maharaj, (unknown), Ryan Ottridge, Sudha Sundar, (unknown)	2
5	Current and future approaches to screening for endometrial cancer 2020 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·A. Gentry-Maharaj, Chloe Karpinskyj	58
6	Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS) 2018 ·BMC Public Health ·Paul Trembling, Sophia Apostolidou, A. Gentry-Maharaj, Julie Parkes, Andy Ryan, Sudeep Tanwar, Matthew Burnell, Usha Menon, William Rosenberg	1
7	The role of transvaginal ultrasound in screening for ovarian cancer 2018 ·Climacteric ·Stuart Campbell, A. Gentry-Maharaj	20
8	Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples 2015 ·British Journal of Cancer ·(unknown), (unknown), Sophia Apostolidou, Richard Gunu, Andy Ryan, Ian Jacobs, Usha Menon, W. Alderton, A. Gentry-Maharaj, John F. Timms	92
9	Abstract 2838: TP53 autoantibody can detect CA125 screen negative ovarian cancer cases and can be elevated prior to CA125 in preclinical ovarian cancer 2015 ·Cancer Research ·(unknown), (unknown), Zhen Lü, Keith Baggerly, Karen H. Lu, A. Gentry-Maharaj, Usha Menon, Ian Jacobs, Robert C. Bast	2
10	Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset 2015 ·BioMed Research International ·Oleg Blyuss, A. Gentry-Maharaj, (unknown), Andy Ryan, Alexey Zaikin, Usha Menon, Ian Jacobs, John F. Timms	21
11	Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening 2013 ·British Journal of Cancer ·A. Gentry-Maharaj, (unknown), Matthew Burnell, Andy Ryan, Sophia Apostolidou, (unknown), Aarti Sharma, Mahesh Parmar, Ian Jacobs, Usha Menon	7
12	115 INFLUENCE OF BMI AND ALCOHOL ON LIVER-RELATED MORBIDITY AND MORTALITY IN A COHORT OF 108,000 WOMEN FROM THE GENERAL POPULATION FROM UKCTOCS 2013 ·Journal of Hepatology ·Paul Trembling, Sophia Apostolidou, Julie Parkes, Andy Ryan, A. Gentry-Maharaj, Sudeep Tanwar, Usha Menon, William Rosenberg	3
13	Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross‐sectional cohort study of 10 418 British women aged 54–65 2011 ·BJOG An International Journal of Obstetrics & Gynaecology ·M. S. Hunter, A. Gentry-Maharaj, Andy Ryan, Matthew Burnell, Anne Lanceley, Lindsay Fraser, Ian Jacobs, Usha Menon	105
14	Significant endometrial pathology detected during a transvaginal ultrasound screening trial for ovarian cancer 2011 ·Gynecologic Oncology ·Robert Woolas, Ahmed Talaat, Mary Ann Anderson, Dirk Brinkmann, (unknown), A. Gentry-Maharaj, A. M. Ryan, Adam N. Rosenthal, Usha Menon, Ian Jacobs	1
15	The UK Collaborative Trial Of Ovarian Cancer Screening (Ukctocs): Recruitment, Randomisation, Initial Screen 2006 ·International Journal of Gynecological Cancer ·A. Gentry-Maharaj	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact